skip to main content

Colchicine renal impairment — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

HardRenal and Hepatic ImpairmentColchicine renal impairmentGPhC CRA

A 69-year-old man with eGFR 18 mL/min/1.73 m² is prescribed colchicine 500 micrograms three times daily for gout. He also takes clarithromycin started yesterday. What is the most important interaction to flag?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: BDo not supply until prescriber review because toxicity risk is high in severe renal impairment and with clarithromycin

Colchicine has a narrow therapeutic index and toxicity risk rises in severe renal impairment. Clarithromycin can markedly increase colchicine exposure through CYP3A4/P-gp inhibition. Severe toxicity can include gastrointestinal symptoms, myelosuppression and multiorgan failure. The prescriber should review therapy urgently before supply.

Reference: BNF